Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus Posted byketaminhJanuary 30, 2015Posted inEmergency medicine and critical care, FOAMEdTags:critical-care, epilepsy, ketamine Great FOAMEd here on role of ketamine in status epilepticus! Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus Share this: Click to print (Opens in new window) Print Click to email a link to a friend (Opens in new window) Email Like Loading...
You must be logged in to post a comment.